Thumbnail Image
Publication

Resolution of coronavirus disease 2019 (COVID-19)

Habas, Khaled S.A.
; 
Nganwuchu, Chinyere C.
; 
Shahzad, F.
; 
Gopalan, Rajendran C.
; 
Haque, M.
; 
Rahman, Sayeeda
; 
Majumder, A.A.
; 
Nasim, Md. Talat
Publication Date
2020
End of Embargo
Supervisor
Keywords
Novel coronavirus, SARS-CoV-2, COVID-19, Severe acute respiratory syndrome coronavirus-2, Diagnosis, Epidemiology, Pathology, Treatment
Rights
© 2020 Taylor & Francis. The Version of Record of this manuscript has been published and is available in Expert Review of Anti-infective Therapy http://www.tandfonline.com/
.
cb
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
13/07/2020
Institution
Department
Awarded
Embargo end date
Collections
Life Sciences Publications
Show all metadata
Files
Thumbnail Image
Accepted manuscript
Adobe PDF, 537.59 KB
Additional title
Abstract
Introduction. Coronavirus disease 2019 (COVID-19) was first detected in China in December, 2019, and declared as a pandemic by the World Health Organization (WHO) on March 11, 2020. The current management of COVID-19 is based generally on supportive therapy and treatment to prevent respiratory failure. The effective option of antiviral therapy and vaccination are currently under evaluation and development. Areas covered. A literature search was performed using PubMed between December 1, 2019–June 23, 2020. This review highlights the current state of knowledge on the viral replication and pathogenicity, diagnostic and therapeutic strategies, and management of COVID-19. This review will be of interest to scientists and clinicians and make a significant contribution toward development of vaccines and targeted therapies to contain the pandemic. Expert Opinion. The exit strategy for a path back to normal life is required, which should involve a multi-prong effort toward development of new treatment and a successful vaccine to protect public health worldwide and prevent future COVID-19 outbreaks. Therefore, the bench to bedside translational research as well as reverse translational works focusing bedside to bench is very important and would provide the foundation for the development of targeted drugs and vaccines for COVID-19 infections.
URI
http://hdl.handle.net/10454/17989
Version
Accepted manuscript
Citation
Habas KSA, Nganwuchu C, Shahzad F et al (2020) Resolution of coronavirus disease 2019 (COVID-19). Expert Review of Anti-infective Therapy. 18(12): 1201-1211.
Link to publisher’s version
Link to published version
Link to Version of Record
https://doi.org/10.1080/14787210.2020.1797487
Type
Article
Qualification name
Notes